A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/1999
12/21/1999	US6004555 Methods for the specific coagulation of vasculature
12/21/1999	US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999	US6004535 Methods of imaging neoplastic disease and of detecting and quantifying MN protein/polypeptide using MN-specific antibodies
12/21/1999	US6004533 Radionuclide labeling of vitamin B12 and coenzymes thereof
12/21/1999	US6004532 Formulation for Tin-117m /diethylenetriaminepentaacetic acids
12/21/1999	US6004531 Metal chelating compounds having an SNNN donor set
12/21/1999	US6004529 Chelating agents
12/16/1999	WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999	WO1999064051A1 Novel antibacterial compounds
12/16/1999	WO1999064049A1 Novel antibacterial agents
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064046A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999	WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999	WO1999064043A1 Muscarinic receptor antagonists
12/16/1999	WO1999064040A1 Novel polyene macrolide compounds and uses
12/16/1999	WO1999064039A1 Bradykinin antagonists
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	WO1999056790A3 13c glucose breath test for the diagnosis of diabetes
12/16/1999	DE19826307A1 CD4 radio immunological pharmaceuticals
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319730A1 Bradykinin antagonists
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999	CA2315883A1 Muscarinic receptor antagonists
12/15/1999	EP0963209A2 Improvements in or relating to diagnostic/therapeutic agents
12/15/1999	EP0963182A1 Method of treating a disease process in a luminal structure
12/15/1999	CN1238702A Radiolabeled DNA oligonuleotide, method of preparation and therapeutic uses
12/15/1999	CN1238700A Improvents in or relating to diagnostic/therapeutic agents
12/14/1999	US6001979 Cores for technetium radiopharmaceuticals
12/14/1999	US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents
12/14/1999	US6001331 Introducing into patient benzylthiazol-3-ium derivatives of given formula; allowing time for compound to associate with amyloid; detecting the labeled compound associated with amyloid deposits
12/14/1999	US6001329 Radiolabeled fusion toxins for cancer therapy
12/14/1999	CA2172607C Phorbine derivatives and their use in the diagnosis and therapy of cancer
12/14/1999	CA2065150C Inhibitors of thrombin
12/09/1999	WO1999062565A2 Patient-specific dosimetry
12/09/1999	WO1999062564A1 Radioiodinated phenols for brachytherapy
12/09/1999	WO1999062563A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/09/1999	CA2331064A1 Patient-specific dosimetry
12/09/1999	CA2299389A1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/08/1999	EP0961591A1 Method to enhance tissue accumulation of radiolabeled compounds
12/08/1999	EP0711178A4 Blood pool imaging composition and method of its use
12/08/1999	EP0594837B2 Radiolabelled compound formulations
12/08/1999	CN1237457A Re-188-rhenium sulfide suspension preparation, preparation method and its application
12/08/1999	CN1237414A Microcapsule containing chemotherapeutic medicine and capsule-forming method
12/07/1999	US5997845 Technetium-99M labeled peptides for imaging inflammation
12/07/1999	US5997844 Technetium-99m labeled peptides for imaging
12/07/1999	US5997843 Radiometal complexes that localise in hypoxic tissue
12/07/1999	US5997842 Radionuclide excited phosphorescent material for administering PDT
12/02/1999	WO1999061097A2 Alpha emitting constructs and uses thereof
12/02/1999	WO1999061072A2 Methods of inhibiting clot formation
12/02/1999	WO1999061071A2 Assay in vivo of labeled triplex-forming oligonucleotides
12/02/1999	WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999	WO1999061023A1 Cocaine receptor binding ligands
12/02/1999	CA2333592A1 Methods of inhibiting clot formation
12/01/1999	EP0960623A2 Kit for the single step preparation of pentavalent technetium 99mTc(V)-DMSA
12/01/1999	EP0959904A2 Hybrid compositions for intracellular targeting
12/01/1999	EP0833646B1 Multi-tyrosinated somatostatin analogs
12/01/1999	EP0783325B1 Contrast agent
12/01/1999	CN1046857C Tris (isonitrile) copper sulfates and its preparing process
11/1999
11/30/1999	US5994535 Water soluble texaphyrin metal complex preparation
11/30/1999	US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999	US5994060 Gro genes, proteins, and uses thereof
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993813 Family of high affinity, modified antibodies for cancer treatment
11/30/1999	US5993777 Benzamide compounds for cancer imaging and therapy
11/30/1999	US5993776 Radiopharmaceutical compositions that include an inclusion complex of a cyclodextrin and a radio-halogenated fatty acid
11/30/1999	US5993775 Peptides which bind technetium or rhenium and which can be targeted to specific sites within a mammalian body.
11/30/1999	US5993774 Metal-oxime chelates for use as radiopharmaceutical agents
11/30/1999	US5993374 Microcapsules for site-specific delivery
11/30/1999	CA2019035C Stabilized radiopharmaceutical compositions
11/25/1999	WO1999060404A1 Multi-partite ligands and methods of identifying and using same
11/25/1999	WO1999060018A1 Labelled glutamine and lysine analogues
11/25/1999	WO1999059642A1 Labeled drugs and nitroxyl compounds to be used therein
11/25/1999	WO1999059640A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
11/25/1999	WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999	WO1998018500A8 Improvements in or relating to diagnostic/therapeutic agents
11/25/1999	CA2332277A1 Labelled glutamine and lysine analogues
11/25/1999	CA2328401A1 Multi-partite ligands and methods of identifying and using same
11/24/1999	EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999	CN1235960A Mercapto-alkyl monosubstituted O-phenylene diamine derivatives, its preparation and radio nuclide compound
11/23/1999	US5990286 Antibodies with reduced net positive charge
11/23/1999	US5989520 Biotinylated lipid coated emulsion containing a paramagnetic element and a fluorochemical
11/23/1999	US5989519 Technetium-99m labeled peptides for imaging inflammation
11/18/1999	WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
11/18/1999	WO1999058162A2 Pharmaceuticals for the imaging of angiogenic disorders

1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 243